Answer to the Letter to the Editor: Methotrexate in interstitial lung disease associated with rheumatoid arthritis
Reumatol Clin (Engl Ed)
.
2022 Aug-Sep;18(7):440-441.
doi: 10.1016/j.reumae.2020.12.001.
Epub 2021 Jul 27.
Authors
Carmen Carrasco Cubero
1
,
Eugenio Chamizo Carmona
2
Affiliations
1
Servicio de Reumatología, Hospital Universitario de Badajoz, Badajoz, Spain. Electronic address: mcarrascocubero@gmail.com.
2
Servicio de Reumatología, Hospital General de Mérida, Mérida, Badajoz, Spain.
PMID:
34326036
DOI:
10.1016/j.reumae.2020.12.001
No abstract available
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid* / complications
Arthritis, Rheumatoid* / drug therapy
Humans
Lung Diseases, Interstitial* / complications
Methotrexate / adverse effects
Substances
Methotrexate